Obesity-Induced Hypertension Interaction of Neurohumoral and Renal Mechanisms

被引:888
作者
Hall, John E. [1 ,3 ,4 ]
do Carmo, Jussara M. [1 ,3 ,4 ]
da Silva, Alexandre A. [1 ,3 ,4 ]
Wang, Zhen [1 ,3 ,4 ]
Hall, Michael E. [1 ,2 ,3 ,4 ]
机构
[1] Univ Mississippi, Dept Physiol & Biophys, Med Ctr, Jackson, MS 39216 USA
[2] Univ Mississippi, Dept Med, Med Ctr, Jackson, MS 30216 USA
[3] Univ Mississippi, Mississippi Ctr Obes Res, Med Ctr, Jackson, MS 30216 USA
[4] Univ Mississippi, Cardiovasc Renal Res Ctr, Med Ctr, Jackson, MS 30216 USA
关键词
blood pressure; chronic renal insufficiency; kidney; leptin; melanocortins; mineralocorticoids; SYMPATHETIC-NERVOUS-SYSTEM; RENIN-ANGIOTENSIN SYSTEM; SELECTIVE LEPTIN RESISTANCE; CHRONIC KIDNEY-DISEASE; BODY-MASS-INDEX; BLOOD-PRESSURE; ARTERIAL-PRESSURE; MELANOCORTIN SYSTEM; NATRIURETIC PEPTIDES; CARDIOVASCULAR FUNCTIONS;
D O I
10.1161/CIRCRESAHA.116.305697
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension, accounting for 65% to 75% of the risk for human primary (essential) hypertension. Increased renal tubular sodium reabsorption impairs pressure natriuresis and plays an important role in initiating obesity hypertension. The mediators of abnormal kidney function and increased blood pressure during development of obesity hypertension include (1) physical compression of the kidneys by fat in and around the kidneys, (2) activation of the renin-angiotensin-aldosterone system, and (3) increased sympathetic nervous system activity. Activation of the renin-angiotensin-aldosterone system is likely due, in part, to renal compression, as well as sympathetic nervous system activation. However, obesity also causes mineralocorticoid receptor activation independent of aldosterone or angiotensin II. The mechanisms for sympathetic nervous system activation in obesity have not been fully elucidated but may require leptin and activation of the brain melanocortin system. With prolonged obesity and development of target organ injury, especially renal injury, obesity-associated hypertension becomes more difficult to control, often requiring multiple antihypertensive drugs and treatment of other risk factors, including dyslipidemia, insulin resistance and diabetes mellitus, and inflammation. Unless effective antiobesity drugs are developed, the effect of obesity on hypertension and related cardiovascular, renal and metabolic disorders is likely to become even more important in the future as the prevalence of obesity continues to increase.
引用
收藏
页码:991 / 1006
页数:16
相关论文
共 142 条
[1]   Pathophysiological role of leptin in obesity-related hypertension [J].
Aizawa-Abe, M ;
Ogawa, Y ;
Masuzaki, H ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Matsuoka, N ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Nakao, K .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1243-1252
[2]   Hypertension in obese Zucker rats - Role of angiotensin II and adrenergic activity [J].
AlonsoGalicia, M ;
Brands, MW ;
Zappe, DH ;
Hall, JE .
HYPERTENSION, 1996, 28 (06) :1047-1054
[3]   INCREASED HYALURONIC-ACID IN THE INNER RENAL MEDULLA OF OBESE DOGS [J].
ALONSOGALICIA, M ;
DWYER, TM ;
HERRERA, GA ;
HALL, JE .
HYPERTENSION, 1995, 25 (04) :888-892
[4]   Structural Renal Changes in Obesity and Diabetes [J].
Amann, Kerstin ;
Benz, Kerstin .
SEMINARS IN NEPHROLOGY, 2013, 33 (01) :23-33
[5]   Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet [J].
Armitage, James A. ;
Burke, Sandra L. ;
Prior, Larissa J. ;
Barzel, Benjamin ;
Eikelis, Nina ;
Lim, Kyungjoon ;
Head, Geoffrey A. .
HYPERTENSION, 2012, 60 (01) :163-171
[6]   AUTONOMIC NERVOUS-SYSTEM ACTIVITY IN WEIGHT-GAIN AND WEIGHT-LOSS [J].
ARONNE, LJ ;
MACKINTOSH, R ;
ROSENBAUM, M ;
LEIBEL, RL ;
HIRSCH, J .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1995, 269 (01) :R222-R225
[7]   Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men [J].
Asferg, Camilla L. ;
Nielsen, Soren J. ;
Andersen, Ulrik B. ;
Linneberg, Allan ;
Moller, Daniel V. ;
Hedley, Paula L. ;
Christiansen, Michael ;
Goetze, Jens P. ;
Esler, Murray ;
Jeppesen, Jorgen L. .
HYPERTENSION, 2013, 62 (01) :147-153
[8]   Brain-Derived Neurotrophic Factor/Tropomyosin-Related Kinase Receptor Type B Signaling Is a Downstream Effector of the Brainstem Melanocortin System in Food Intake Control [J].
Bariohay, Bruno ;
Roux, Julien ;
Tardivel, Catherine ;
Trouslard, Jerome ;
Jean, Andre ;
Lebrun, Bruno .
ENDOCRINOLOGY, 2009, 150 (06) :2646-2653
[9]   A Controlled Trial of Renal Denervation for Resistant Hypertension [J].
Bhatt, Deepak L. ;
Kandzari, David E. ;
O'Neill, William W. ;
D'Agostino, Ralph ;
Flack, John M. ;
Katzen, Barry T. ;
Leon, Martin B. ;
Liu, Minglei ;
Mauri, Laura ;
Negoita, Manuela ;
Cohen, Sidney A. ;
Oparil, Suzanne ;
Rocha-Singh, Krishna ;
Townsend, Raymond R. ;
Bakris, George L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) :1393-1401
[10]   Increased renal Na-K-ATPase, NCC, and β-ENaC abundance in obese Zucker rats [J].
Bickel, CA ;
Verbalis, JG ;
Knepper, MA ;
Ecelbarger, CA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (04) :F639-F648